Private Advisor Group, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q3 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Advisor Group, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2020$280,000
-7.9%
5,188
+4.3%
0.00%0.0%
Q2 2020$304,000
+16.5%
4,975
+67.0%
0.00%0.0%
Q4 2019$261,000
-5.1%
2,979
-0.6%
0.00%0.0%
Q3 2019$275,000
-44.6%
2,998
-23.1%
0.00%
-55.6%
Q2 2019$496,000
-18.2%
3,900
+1.2%
0.01%
-25.0%
Q1 2019$606,000
+61.6%
3,854
+1.5%
0.01%
+33.3%
Q4 2018$375,000
-24.4%
3,797
+11.7%
0.01%
-10.0%
Q3 2018$496,000
+33.0%
3,398
+41.7%
0.01%
+66.7%
Q2 2018$373,000
-5.1%
2,398
+4.1%
0.01%
-60.0%
Q1 2018$393,000
-5.3%
2,303
-5.5%
0.02%
-16.7%
Q4 2017$415,000
+15.9%
2,437
-10.5%
0.02%
+100.0%
Q3 2017$358,000
+50.4%
2,723
+7.6%
0.01%
+50.0%
Q2 2017$238,000
-59.8%
2,531
-63.9%
0.01%
-64.7%
Q1 2017$592,000
+158.5%
7,013
+99.3%
0.02%
+112.5%
Q4 2016$229,000
-13.6%
3,518
-7.8%
0.01%
-27.3%
Q3 2016$265,000
-42.3%
3,816
+40.1%
0.01%
-50.0%
Q2 2015$459,000
+111.5%
2,724
+51.8%
0.02%
+69.2%
Q1 2015$217,0001,7950.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,964,000$59,215,0001.36%
Birchview Capital, LP 75,500$2,276,0001.35%
Camber Capital Management LP 1,000,000$30,150,0001.04%
Sessa Capital IM, L.P. 875,000$26,381,0001.02%
Bain Capital Life Sciences Investors, LLC 538,179$16,226,0000.92%
Tarsadia Capital, LLC 100,000$3,015,0000.81%
Bullseye Asset Management LLC 67,872$2,046,0000.76%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,304,246$39,323,0000.58%
MANGROVE PARTNERS IM, LLC 175,178$5,282,0000.53%
Parametrica Management Ltd 37,712$1,080,0000.52%
View complete list of BLUEBIRD BIO INC shareholders